Home > Emerging Regions > Latin America

Latin America

Did you know that conducting a clinical trial in Latin America costs about 30% less than conducting a trial in Western Europe or the US? The Latin American pharmaceutical market is ever growing, creating a potential for robust sales once the product is approved. Pharmaceutical sales growth in Mexico, Brazil and Argentina account for 80% of regional sales in Latin America and in Brazil alone, the Average Annual Growth Rate suggests an increase in clinical trials of 16%.

By choosing to partner with PAREXEL you will be provided with world class services in a well established region that is unique to other geographical locations in which clinical studies are performed.
A few of the advantages of conducting clinical trials in Latin America include:

  • Common language
  • Seasonal reversal
  • Proximity, Latin America’s time zone is the same as the US
  • Access to a large subject population.
  • Knowledge of International Conference on Harmonisation (ICH) guidelines
  • Deep understanding of Good Clinical Practice (GCP) standards
  • Well established regulations governing the conduct of clinical trials and regulatory agencies
  • Patient enrollment exceeds Europe and the US by three to five percent.
  • Study patients receive a higher quality of medical care, creating a strong relationship between the patient and Investigator

PAREXEL has a strong presence in Latin America, and is fully equipped to execute full service clinical trials in this region. Since its establishment, PAREXEL has conducted hundreds of projects within Latin America. Work with a team of dedicated local experts with specialized knowledge,  who are committed to the success of your trial.
Click here to view the PAREXEL offices throughout Latin America, or email info@PAREXEL.com to inquire about our Latin America expertise.